A federal judge has cut the potential damages Covidien's Mallinckrodt subsidiary can receive in its patent infringement case over medical injectors against two U.S. divisions of BraccoLake Success, N.Y.-based E-Z-EM and Acist Medical Systems of Eden Prairie, Minn.